3 completed. 3 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 2 | Completed 2 |
Follow Habits: new trials by email Literature Review of Habits trials Research Report on Habits
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Management of Bruxism in Patients With Implant Overdenture Botulinium toxin type A injection, Maxillary Occlusal Stabilization Splint - Bruxism | Phase 1 | Completed | Delta University for Science and Technology | 48 | 2024-03-24 | 2026-01-23 |
| Occlusal Adjustment as Treatment for Chronic Orofacial Pain Occlusal adjustment, Placebo occlusal adjustment - Temporomandibular Joint Disorders, Orofacial Pain | Phase 1 / Phase 2 | Completed | University of Santiago de Compostela | 21 | 2009-05-01 | 2013-07-26 |
| Antibody and Safety Study of 6 Doses of NicVAX in Smokers 3'-aminomethyl-Nic r-EPA Conjugate (NicVAX®) - Smoking | Phase 1 / Phase 2 | Completed | Nabi Biopharmaceuticals | 74 | 2008-01-01 | 2012-05-09 |
Bruxism (2) · Facial Pain (1) · Pain (1) · Smoking (1) · Temporomandibular Joint Disorders (1) · Temporomandibular Joint Dysfunction Syndrome (1)
Behavior (3) · Stomatognathic Diseases (2) · Tooth Diseases (2) · Craniomandibular Disorders (1) · Jaw Diseases (1) · Joint Diseases (1) · Mandibular Diseases (1) · Muscular Diseases (1) · Musculoskeletal Diseases (1) · Myofascial Pain Syndromes (1) · Neurologic Manifestations (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1)
Botulinum Toxins, Type A (1) · NicVAX (1) · Occlusal Adjustment (1)
Delta University for Science and Technology (1) · Nabi Biopharmaceuticals (1) · University of Santiago de Compostela (1)
Egypt (1) · Spain (1) · United States (1)
Matt Hohenboken, MD, PhD (1) · Wafaa I Ibrahim, Assoc. Prof. (1)